Relmada Therapeutics (RLMD) Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry - StreetInsider.com

Submitted by Anonymous (not verified) on Wed, 12/22/2021 - 14:05

Relmada Therapeutics (RLMD) Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry  StreetInsider.com